JAZZ insider transactions
Jazz Pharmaceuticals plc (JAZZ) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for JAZZ
- President & CEO Gala Renee D gifted 600 units of Ordinary Shares, decreasing direct ownership by 0.39% to 152,196 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C sold $1,410,720 worth of Ordinary Shares (6,000 units at $235.12) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 372,682 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP & Chief Legal Officer Patil Neena M sold $282,468 worth of Ordinary Shares (1,192 units at $236.97) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 52,626 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP, Chief Commercial Officer Pearce Samantha exercised 6,907 units of Ordinary Shares at a strike of $109.45 and sold $1,625,977 worth of Ordinary Shares (6,907 units at $235.41) (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Mulligan Seamus exercised 3,415 units of Ordinary Shares at a strike of $138.08, increasing direct ownership by 0.29% to 1,183,028 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Winningham Rick E exercised 3,415 units of Ordinary Shares at a strike of $138.08 and sold $662,143 worth of Ordinary Shares (2,741 units at $241.57), increasing direct ownership by 8% to 9,567 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Mcsharry Heather Ann sold $482,000 worth of Ordinary Shares (2,000 units at $241.00), decreasing direct ownership by 10% to 18,449 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C sold $1,219,980 worth of Ordinary Shares (6,000 units at $203.33) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 378,682 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SEC Form 4 filed by Cozadd Bruce C4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C covered exercise/tax liability with 15,114 units of Ordinary Shares, decreasing direct ownership by 4% to 390,682 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP & Chief Financial Officer Johnson Philip L covered exercise/tax liability with 2,615 units of Ordinary Shares, decreasing direct ownership by 4% to 59,608 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Technical Operations Henderson Mary Elizabeth covered exercise/tax liability with 1,394 units of Ordinary Shares, decreasing direct ownership by 5% to 27,334 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP, Chief Commercial Officer Pearce Samantha covered exercise/tax liability with 2,503 units of Ordinary Shares, decreasing direct ownership by 5% to 50,272 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP, Global Head of R&D & CMO Iannone Robert covered exercise/tax liability with 6,209 units of Ordinary Shares, decreasing direct ownership by 7% to 88,871 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Chief Accounting Officer Carr Patricia covered exercise/tax liability with 1,436 units of Ordinary Shares and sold $235,444 worth of Ordinary Shares (1,287 units at $182.94), decreasing direct ownership by 29% to 6,512 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- President & CEO Gala Renee D covered exercise/tax liability with 7,065 units of Ordinary Shares, decreasing direct ownership by 4% to 152,630 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP & Chief Legal Officer Patil Neena M covered exercise/tax liability with 5,000 units of Ordinary Shares, decreasing direct ownership by 9% to 53,818 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C sold $1,118,613 worth of Ordinary Shares (6,000 units at $186.44), decreasing direct ownership by 1% to 405,796 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Riedel Norbert G exercised 3,415 units of Ordinary Shares at a strike of $138.08 and sold $655,680 worth of Ordinary Shares (3,415 units at $192.00) (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP & Chief Financial Officer Johnson Philip L was granted 11,857 units of Ordinary Shares, increasing direct ownership by 24% to 62,223 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP, Chief Commercial Officer Pearce Samantha was granted 9,782 units of Ordinary Shares, increasing direct ownership by 23% to 52,775 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP, Global Head of R&D & CMO Iannone Robert was granted 14,822 units of Ordinary Shares, increasing direct ownership by 18% to 95,080 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Chief Accounting Officer Carr Patricia was granted 2,223 units of Ordinary Shares and sold $456,466 worth of Ordinary Shares (2,370 units at $192.60), decreasing direct ownership by 2% to 9,235 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- President & CEO Gala Renee D was granted 44,465 units of Ordinary Shares, increasing direct ownership by 39% to 159,695 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Love Ted W was granted 1,527 units of Ordinary Shares (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP & Chief Legal Officer Patil Neena M exercised 51,000 units of Ordinary Shares at a strike of $127.23, sold $10,650,482 worth of Ordinary Shares (55,600 units at $191.56) and was granted 10,079 units of Ordinary Shares, increasing direct ownership by 10% to 58,818 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Technical Operations Henderson Mary Elizabeth was granted 4,447 units of Ordinary Shares and sold $1,039,134 worth of Ordinary Shares (5,343 units at $194.49), decreasing direct ownership by 3% to 28,728 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Technical Operations Henderson Mary Elizabeth was granted 10,116 units of Ordinary Shares, increasing direct ownership by 52% to 29,624 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Chief Accounting Officer Carr Patricia was granted 2,370 units of Ordinary Shares, increasing direct ownership by 34% to 9,382 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP & Chief Legal Officer Patil Neena M was granted 8,852 units of Ordinary Shares and returned $560,549 worth of Ordinary Shares to the company (3,275 units at $171.16), increasing direct ownership by 12% to 53,339 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP, Chief Commercial Officer Pearce Samantha was granted 3,637 units of Ordinary Shares and covered exercise/tax liability with 1,599 units of Ordinary Shares, increasing direct ownership by 5% to 42,993 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP, Global Head of R&D & CMO Iannone Robert was granted 11,699 units of Ordinary Shares and covered exercise/tax liability with 4,140 units of Ordinary Shares, increasing direct ownership by 10% to 80,258 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- President & CEO Gala Renee D was granted 12,741 units of Ordinary Shares and covered exercise/tax liability with 5,371 units of Ordinary Shares, increasing direct ownership by 7% to 115,230 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C was granted 35,917 units of Ordinary Shares and covered exercise/tax liability with 17,453 units of Ordinary Shares, increasing direct ownership by 5% to 411,796 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Enright Patrick G disposed of 5,000 units of Ordinary Shares, decreasing direct ownership by 19% to 21,379 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Technical Operations Henderson Mary Elizabeth sold $379,366 worth of Ordinary Shares (2,238 units at $169.51), decreasing direct ownership by 10% to 19,508 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SEC Form 3 filed by new insider Love Ted W3 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- President & CEO Gala Renee D covered exercise/tax liability with 80 units of Ordinary Shares, decreasing direct ownership by 0.07% to 107,860 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Chief Accounting Officer Carr Patricia sold $797,783 worth of Ordinary Shares (4,660 units at $171.20) and exercised 4,500 units of Ordinary Shares at a strike of $140.67, decreasing direct ownership by 2% to 7,012 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director O'Keefe Kenneth W covered exercise/tax liability with 603 units of Ordinary Shares, decreasing direct ownership by 2% to 25,811 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C exercised 77,500 units of Ordinary Shares at a strike of $123.36 and sold $13,780,337 worth of Ordinary Shares (77,500 units at $177.81) (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Mcsharry Heather Ann sold $607,127 worth of Ordinary Shares (3,415 units at $177.78) and exercised 3,415 units of Ordinary Shares at a strike of $138.08 (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Technical Operations Henderson Mary Elizabeth returned $240,112 worth of Ordinary Shares to the company (1,331 units at $180.40), decreasing direct ownership by 6% to 21,746 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C sold $3,259,538 worth of Ordinary Shares (18,000 units at $181.09) and was granted 2,506 units of Ordinary Shares, decreasing direct ownership by 4% to 393,332 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- SVP, Chief Accounting Officer Carr Patricia sold $968,402 worth of Ordinary Shares (5,319 units at $182.06) and exercised 5,250 units of Ordinary Shares at a strike of $136.18, decreasing direct ownership by 0.97% to 7,012 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Winningham Rick E sold $994,728 worth of Ordinary Shares (5,500 units at $180.86), decreasing direct ownership by 38% to 8,893 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- EVP, Global Head of R&D & CMO Iannone Robert sold $1,204,573 worth of Ordinary Shares (7,159 units at $168.26), decreasing direct ownership by 9% to 72,628 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C sold $753,560 worth of Ordinary Shares (5,500 units at $137.01), decreasing direct ownership by 1% to 408,826 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C covered exercise/tax liability with 15,647 units of Ordinary Shares, decreasing direct ownership by 4% to 414,326 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cozadd Bruce C sold $771,690 worth of Ordinary Shares (6,000 units at $128.62), decreasing direct ownership by 1% to 429,973 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director O'Keefe Kenneth W was granted 3,507 units of Ordinary Shares and covered exercise/tax liability with 1,805 units of Ordinary Shares, increasing direct ownership by 6% to 28,672 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Cook Jennifer E. was granted 3,507 units of Ordinary Shares and covered exercise/tax liability with 1,805 units of Ordinary Shares, increasing direct ownership by 19% to 10,837 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Enright Patrick G was granted 3,507 units of Ordinary Shares and covered exercise/tax liability with 1,805 units of Ordinary Shares, increasing direct ownership by 7% to 26,379 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Hamill Laura covered exercise/tax liability with 1,805 units of Ordinary Shares and was granted 3,507 units of Ordinary Shares, increasing direct ownership by 33% to 6,933 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Kennedy Patrick was granted 3,507 units of Ordinary Shares and covered exercise/tax liability with 1,959 units of Ordinary Shares, increasing direct ownership by 30% to 6,702 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Mcsharry Heather Ann was granted 3,507 units of Ordinary Shares and covered exercise/tax liability with 1,959 units of Ordinary Shares, increasing direct ownership by 8% to 20,449 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Oriordan Anne covered exercise/tax liability with 1,805 units of Ordinary Shares and was granted 3,507 units of Ordinary Shares, increasing direct ownership by 12% to 16,500 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Riedel Norbert G was granted 3,507 units of Ordinary Shares and covered exercise/tax liability with 1,805 units of Ordinary Shares, increasing direct ownership by 32% to 7,024 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Smith Mark Douglas was granted 3,507 units of Ordinary Shares and covered exercise/tax liability with 1,805 units of Ordinary Shares, increasing direct ownership by 19% to 10,837 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)
- Director Winningham Rick E was granted 3,507 units of Ordinary Shares and covered exercise/tax liability with 1,805 units of Ordinary Shares, increasing direct ownership by 13% to 14,393 units (SEC Form 4)4 - Jazz Pharmaceuticals plc (0001232524) (Issuer)